Why PSS World Medical's Shares Got Crushed

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of health-care products distributor PSS World Medical (Nasdaq: PSSI  ) were looking ill today, as they fell as much as 15% in intraday trading after the company announced fiscal fourth-quarter results.

So what: It's generally not good news when a company announces a "strategic transformation plan," as PSS did today. If we follow the classic advice of "if it ain't broke, don't fix it," then a transformational effort likely means that something is indeed broken. A look at PSS's March-quarter results suggests that that assumption may be on target.

For the quarter, sales fell 2% from last year, and the $539 million the company reported was short of the $556 million analysts were looking for. On the bottom line, earnings per share of $0.38 were flat from a year ago, but noticeably below the $0.43 that Wall Street expected.

Now what: The distributor's restructuring will aim to focus its business on faster-growing segments: physician, laboratory, in-office dispensing, and home and hospice care. It plans to divest its skilled nursing and specialty dental businesses. If management is able to hit its goals for the transformation it could work out well for investors. CEO Gary Corless said they're targeting doubling revenue and bringing operating margins to above 10% over "the next several years." For the sake of comparison, fiscal 2012 operating margins were 6.4%, and they were 6.6% in fiscal 2011.

But whether it will work out as management hopes is another matter. For today at least, investors seem skeptical.

Want to keep up to date on PSS World Medical? Add it to your Watchlist.

Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

Fool contributor Matt Koppenheffer has no financial interest in any of the companies mentioned. You can check out what Matt is keeping an eye on by visiting his CAPS portfolio, or you can follow Matt on Twitter, @KoppTheFool, or on Facebook. The Fool's disclosure policy prefers dividends over a sharp stick in the eye.


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1884865, ~/Articles/ArticleHandler.aspx, 8/20/2014 12:53:58 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement